27/02/2026
Breast cancer treatment changes your biology.
And so can cancer itself.
If you’ve noticed more fatigue, bloating, muscle weakness, slower recovery or reduced resilience, there is physiology behind that shift.
Cancer and its treatment can increase systemic inflammation, alter mitochondrial function, reduce muscle mass, disrupt the gut microbiome and accelerate bone turnover, particularly during aromatase inhibitor therapy.
This isn’t “just aging.”
It’s treatment-related physiology.
Chemotherapy has been shown to influence molecular aging markers, including telomere biology
Exercise oncology research shows that structured resistance and aerobic training can:
• Improve mitochondrial function
• Reduce chronic inflammation
• Enhance insulin sensitivity
• Increase microbial diversity
• Support bone density
• Improve quality of life by ~20% in breast cancer survivors
(Hojman et al., Nat Rev Cancer, 2018; Courneya et al., J Clin Oncol, 2007; Denham et al., Exp Gerontol, 2016)
⭐️Muscle is not cosmetic tissue.
It’s endocrine, metabolic and anti-inflammatory.
For women on aromatase inhibitors where bone turnover is already elevated, rebuilding muscle and reducing inflammation is central to protecting your spine and long-term health.
If you want progressive training designed specifically for post-breast cancer physiology and aromatase inhibitor bone loss -
That’s exactly what we build inside my 1:1.
DM REBUILD.
Never too late to change your trajectory 📈
Sanoff et al., JNCI, 2014
Hojman et al., Nat Rev Cancer, 2018; Courneya et al., J Clin Oncol, 2007; Denham et al., Exp Gerontol, 2016